FindTrial
Sign In

Sarcopenia in Liver Cirrhosis â?? A cross-sectional study

Prevalence and factors associated with Sarcopenia in Liver Cirrhosis â?? A cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/12/016699
Enrollment
130
Registered
2018-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

None listed

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with biochemical, radiologic or histopathologic evidence (wherever available) of liver cirrhosis

Exclusion criteria

Exclusion criteria: Patients with other conditions that can cause muscle wasting like chronic renal failure, malignancy, chronic inflammatory / infectious diseases [HIV, TB, HCC, chronic pancreatitis and with long standing Diabetes Mellitus [ >10 years]

Design outcomes

Primary

MeasureTime frame
Prevalence of Sarcopenia in Liver cirrhosis in this subgroup of patients Assessment of reliable factors associated with development of Sarcopenia in Liver cirrhosis Timepoint: 6 months—

Secondary

MeasureTime frame
Correlation of Sarcopenia with consequences and complications of liver cirrhosis and portal hypertension, also with CTP and MELD-Na scoresTimepoint: 6 months—

Countries

India

Contacts

Public ContactNeil Palkhiwala

Kasturba Medical College Manipal

cg.pai@manipal.edu9945376424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026